5-(2-Carboxythiophen-5-y l)-16-aryloxy-.alpha.-tetranor-.omega.-tetranorprostaglandins
US4065472A · kind A · utility
1Cited by
1References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 29, 1975 |
| Grant date | Dec 27, 1977 |
| Priority date | — |
| Expiry date | Sep 29, 1995 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/655345
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
5-(2-Carboxythiophen-5-yl)-16-aryloxy-.alpha.-tetranor-.omega.-tetranorpros taglandins and intermediates useful in their preparation are disclosed. The novel prostaglandins of this invention have been found to have activity profiles comparable to the parent prostaglandins but they exhibit a greater tissue specificity of action.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.